Are you diagnosed with…
- MET exon 14 skipping?
- MET amplification?
- MET overexpression?
- MET-altered cancer, no matter what tumor type?
The MET Crusaders is your global, pan-tumor, biomarker support group for patients, care partners, and families.
Get help with your MET diagnosis now by phone, 602-618-0183; or email, info@metcrusaders.org.
MET CRUSADERS RECAPS
Check out MET Crusaders’ Recaps
ASCO 2026 Annual Meeting
Just click on the flipbooks!
EMRELIS™ (Teliso-V) is the approved drug for NSCLC MET Overexpression!